
Nine new medication have come substantially closer to a European launch during June after the Committee for Medicinal Products for Human Use (CHMP) has given a positive recommendation of the treatments.
These medications are now on the verge gaining a European marketing permit being that CHMP’s recommendations are customarily followed by the EU Commission, the formal authorizing institution.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app